Wave Life Sciences Ltd. (WVE) Financial Statements
Wave Life Sciences Ltd. (WVE) reported trailing twelve-month revenue of $65.4M (down 30.4% year on year) and net income of -$202.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$193.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WVEWave Life Sciences Ltd.Follow WVE — free
—
Price chart with a free account
- Market cap
- 626.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.2 | 1.5 | 3.7 | 14.4 | 16.0 | 20.1 | 41.0 | 3.6 | 113.3 | 108.3 | 42.7 | 65.4 | |
| Research & development | 9.1 | 40.8 | 79.3 | 134.4 | 175.4 | 130.9 | 121.9 | 115.9 | 130.0 | 159.7 | 182.8 | 197.4 | |
| Operating income | -19.3 | -55.7 | -102.4 | -159.5 | -208.3 | -153.4 | -127.0 | -162.7 | -68.0 | -110.4 | -215.4 | -217.9 | |
| Pre-tax income | -19.2 | -55.2 | -101.1 | -146.6 | -193.6 | -150.8 | -122.4 | -161.1 | -58.2 | -97.0 | -204.4 | -202.5 | |
| Income tax | 0.0 | 0.5 | 0.8 | 0.1 | 0.0 | -0.8 | -0.2 | 0.7 | -0.7 | 0.0 | 0.0 | 0.0 | |
| Net income | -19.2 | -55.7 | -102.0 | -146.7 | -193.6 | -149.9 | -122.2 | -161.8 | -57.5 | -97.0 | -204.4 | -202.5 | |
| Diluted EPS ($) | -1.83 | -2.44 | -3.85 | -5.06 | -5.72 | -3.82 | -2.36 | -2.05 | -0.54 | -0.70 | -1.21 | -0.99 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | 78.9 | 106.1 | 138.3 | 168.6 | — |
USD millions · SEC XBRL
Wave Life Sciences Ltd. — questions
- What is Wave Life Sciences Ltd.'s revenue?
- $65.4M over the twelve months to 2026-06-30, down 30.4% year on year, from its 10-Q and 10-K filings.
- What is Wave Life Sciences Ltd.'s net income?
- -$202.5M over the twelve months to 2026-06-30.
- What is Wave Life Sciences Ltd.'s free cash flow?
- -$193.1M over the twelve months to 2026-06-30.
- What are Wave Life Sciences Ltd.'s diluted earnings per share?
- $-0.99 over the twelve months to 2026-06-30.
Every figure on this page comes from Wave Life Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.